| Phase 2 |
| NCT06353997 |
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients |
Triple Negative Breast Cancer |
Recruiting |
| NCT05913388 |
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic… |
Metastatic Melanoma |
Recruiting |
| NCT04938609 |
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) |
Head and Neck Cancer |
Active, Not Recruiting |
| NCT02688712 |
ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer |
Rectal Adenocarcinoma |
Active, Not Recruiting |
| NCT03650894 |
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative… |
Breast Neoplasm Female |
Active, Not Recruiting |
| NCT04061980 |
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With… |
BRAF NP_004324.2:p.V600M |
Active, Not Recruiting |
| NCT01416831 |
Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With… |
Metastatic Melanoma |
Active, Not Recruiting |
| NCT04373031 |
Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer |
Breast Cancer |
Active, Not Recruiting |
| Phase 1/2 |
| NCT02422381 |
MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) |
Carcinoma, Non-Small-Cell Lung |
Active, Not Recruiting |
| NCT02734290 |
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer |
Triple Negative Breast Cancer |
Active, Not Recruiting |
| Phase 1 |
| NCT04470024 |
Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With… |
Cancer of the Head and Neck |
Recruiting |
| NCT07408856 |
CAN1012 in Pre-Malignant DCIS and LCIS |
Ductal Carcinoma in Situ |
Not Yet Recruiting |
| NCT04520711 |
Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor… |
Malignant Epithelial Neoplasms |
Active, Not Recruiting |
| NCT04895761 |
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in… |
Breast Cancer |
Active, Not Recruiting |
| NCT05249114 |
Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive… |
Neuroendocrine Tumors |
Active, Not Recruiting |
| NCT02812524 |
Ipilimumab for Head and Neck Cancer Patients |
Squamous Cell Carcinoma of the Head and Neck |
Active, Not Recruiting |
| NCT05349890 |
Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T… |
Malignant Epithelial Neoplasms |
Active, Not Recruiting |
| NCT07620496 |
CAN1012 in Pre-malignant Oral Dysplasia |
Oral Epithelial Dysplasia (OED) |
Not Yet Recruiting |
| Not specified |
| NCT05508984 |
Clinical Outcomes and Patient Satisfaction With Use of the Amma System |
Breast Cancer |
Active, Not Recruiting |